中华实验眼科杂志
中華實驗眼科雜誌
중화실험안과잡지
CHINESE JOURNAL OF EXPERIMENTAL OPHTHALMOLOGY
2014年
3期
278-280
,共3页
多巴胺/代谢%视网膜/代谢%近视/预防,控制%弱视/预防,治疗%眼压/调节%眼/生长,发育
多巴胺/代謝%視網膜/代謝%近視/預防,控製%弱視/預防,治療%眼壓/調節%眼/生長,髮育
다파알/대사%시망막/대사%근시/예방,공제%약시/예방,치료%안압/조절%안/생장,발육
Dopamine/metabolism%Retina/metabolism%Myopia/prevention and control%Amblyopia/prevention and treatment%Intraocular pressure/regulation%Eye/growth and development
多巴胺是中枢神经递质之一,在人体内与相应的膜受体结合后可激活或抑制环磷酸腺苷(cAMP)的活性,从而调控细胞的钙信号;同时多巴胺也是视网膜中一种主要的神经递质与调质,在整个视觉通路中参与视觉系统的信号传递与调控过程,如视网膜、外侧膝状体、视皮层等.近年来研究发现,多巴胺量的变化影响弱视、近视眼的形成,此外,它还通过与受体结合参与眼压的调控,这些研究对眼科临床上弱视的治疗、近视的预防和眼压的控制等方面提供了新的思路.就视网膜中多巴胺在调控形觉剥夺、光学离焦诱导的近视眼形成、眼压的调节、眼轴的发育及弱视的形成与治疗等方面的研究进展进行综述.
多巴胺是中樞神經遞質之一,在人體內與相應的膜受體結閤後可激活或抑製環燐痠腺苷(cAMP)的活性,從而調控細胞的鈣信號;同時多巴胺也是視網膜中一種主要的神經遞質與調質,在整箇視覺通路中參與視覺繫統的信號傳遞與調控過程,如視網膜、外側膝狀體、視皮層等.近年來研究髮現,多巴胺量的變化影響弱視、近視眼的形成,此外,它還通過與受體結閤參與眼壓的調控,這些研究對眼科臨床上弱視的治療、近視的預防和眼壓的控製等方麵提供瞭新的思路.就視網膜中多巴胺在調控形覺剝奪、光學離焦誘導的近視眼形成、眼壓的調節、眼軸的髮育及弱視的形成與治療等方麵的研究進展進行綜述.
다파알시중추신경체질지일,재인체내여상응적막수체결합후가격활혹억제배린산선감(cAMP)적활성,종이조공세포적개신호;동시다파알야시시망막중일충주요적신경체질여조질,재정개시각통로중삼여시각계통적신호전체여조공과정,여시망막、외측슬상체、시피층등.근년래연구발현,다파알량적변화영향약시、근시안적형성,차외,타환통과여수체결합삼여안압적조공,저사연구대안과림상상약시적치료、근시적예방화안압적공제등방면제공료신적사로.취시망막중다파알재조공형각박탈、광학리초유도적근시안형성、안압적조절、안축적발육급약시적형성여치료등방면적연구진전진행종술.
Dopamine is one of neurotransmitters of the central nervous system,and it can activate or inhibit cAMP by binding the corresponding membrane receptor and further regulate calcium signals.Dopamine is also primary neurotransmitter and modulator in retina,and it plays very important roles over the entire visual pathway including retina,lateral geniculate body and visual cortex.Recent study showed that dopamine participates in the pathogenesis of amblyopia and myopia.In addition,it is also involved in the regulation of intraocular pressure (IOP).These studies offered some new clues for the treatment and prevention of amblyopia and myopia as well as the regulation of IOP.Hence,this paper describes the new progress of retinal dopamine in the form deprivation myopia,myopic defocus,the regulation of IOP,the eye growth and the treatment of amblyopia.